Macquarie Group’s Surmodics SRDX Stock Holding History

Macquarie Group’s Portfolio SRDX Stock Details SRDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-138	Closed	-$4.73K	–	2469
2022 Q2	$5K	Hold	138	–	–	﹤0.01%	2531
2022 Q1	$6K	Hold	138	–	–	﹤0.01%	2581
2021 Q4	$7K	Hold	138	–	–	﹤0.01%	2553
2021 Q3	$8K	Hold	138	–	–	﹤0.01%	2567
2021 Q2	$7K	Hold	138	–	–	﹤0.01%	2504
2021 Q1	$8K	Sell	138 -65	-32%	-$3.24K	﹤0.01%	2415
2020 Q4	$9K	Hold	203	–	–	﹤0.01%	2315
2020 Q3	$8K	Hold	203	–	–	﹤0.01%	2304
2020 Q2	$9K	Buy	+203	New	+$7.68K	﹤0.01%	2302
2019 Q1	–	Sell	-621	Closed	-$29K	–	1998
2018 Q4	$29K	Sell	621 -600	-49%	-$36K	﹤0.01%	1707
2018 Q3	$91K	Sell	1,221 -8,378	-87%	-$577K	﹤0.01%	1607
2018 Q2	$530K	Buy	9,599 +8,140	+558%	+$376K	﹤0.01%	1343
2018 Q1	$56K	Buy	+1,459	New	+$45.2K	﹤0.01%	1963
2017 Q4	–	Sell	-3,970	Closed	-$123K	–	2440
2017 Q3	$123K	Buy	+3,970	New	+$108K	﹤0.01%	1875

Other funds holding SRDX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Trigran Investments Northbrook, Illinois $545M AUM 56.2% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

DGI

Disciplined Growth Investors Minneapolis, Minnesota $5.91B AUM 53.97% 1-Year Est. Return

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Macquarie Group's SRDX Position: Q3 2022 in Review

Macquarie Group sold out of Surmodics (SRDX) in Q3 2022, closing a stake of 138 shares — an estimated $4.73K sold.

Macquarie Group first reported a position in SRDX in Q3 2017 and held it in 14 quarters. The position peaked at $530K in Q2 2018. 123 funds tracked by Wall St. Rank hold SRDX as of Q3 2022.

Macquarie Group reported no remaining Surmodics position as of Q3 2022 after selling out during the quarter.
Macquarie Group sold 138 Surmodics shares in Q3 2022, an estimated $4.73K.
Macquarie Group first reported a position in Surmodics in Q3 2017 and held it in 14 quarters.
Macquarie Group's Surmodics position peaked at $530K in Q2 2018.
123 funds tracked by Wall St. Rank held Surmodics as of Q3 2022.

Based on Macquarie Group's 13F filing for Q3 2022, filed 14 Nov 2022.